SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $111K invested in Salarius Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$60K
2
-$28K
3
-$24.4K
4
Millennium Management
Millennium Management
New York
-$23K
5
XSC
X-Square Capital
Puerto Rico
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$58.4K
2
$25K
3
$25K
4
$2K
5
$366
6
$97
7
$72
8
$23
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–